head_banner

Nūhou

ʻO ka 3rd China International Biological & Chemical Pharmaceutical Industry Conference

21

ʻO ka 3 CMC-Kina 2021
Manawa: Kepakemapa 29-30, 2021
Wahi Hōʻikeʻike: CD Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, Kina.
ʻO Synergy of Centralized China's Drug Volume-based Purchasing and Medical Insurance Negotiation Policy e hoʻoikaika i ka ʻeha o ka hoʻohui ʻana i nā ʻoihana lāʻau lapaʻau a hoʻomaikaʻi i ka maikaʻi o nā lāʻau lapaʻau maʻamau. Ua wehe ʻia nā lāʻau lapaʻau mai ka ʻinikua lapaʻau, e hoʻokuʻu ana i nā wahi hou aku no nā lāʻau lapaʻau me ka waiwai noiʻi noiʻi maoli: ʻO NMPA hui pū ʻana me ICH a me ka hoʻokō ʻana o ka ʻōnaehana MAH i hoʻonui i ka wikiwiki o ka hoʻomohala ʻana i nā papahana lāʻau lapaʻau hou.

No ka manawa lōʻihi, ua nānā ka ʻoihana lāʻau lapaʻau i ka "hou" a nānā ʻole i ka noi lāʻau lapaʻau e like me nā kūlana aupuni a me nā kaulahao ʻoihana lāʻau holoʻokoʻa, e like me ke koi hoʻohui ʻana o nā kikowaena API a me nā kaulahao hoʻolako; ʻO nā lāʻau lapaʻau hou.

Pehea e hele ai ka ʻoihana lāʻau lapaʻau me nā ʻano Kina i ka wā e hiki mai ana? ʻAʻole kēia he pilikia wale nō ma ka ʻaoʻao R&D lāʻau lapaʻau, akā pono nō hoʻi e noʻonoʻo i ke kaulahao ʻoihana lāʻau holoʻokoʻa.

Sepatemaba 29 a 30, 2021, e mālama ʻia ke kolu o ka China Chemical and Biological Pharmaceutical Industry Conference ma Suzhou International Expo Center. ʻO ke kumumanaʻo o ka ʻaha kūkā ʻo "Hoʻohui i ke kaulahao ʻoihana lāʻau lapaʻau holoʻokoʻa e hoʻoponopono i ka koi lāʻau lapaʻau ʻole e like me nā kūlana aupuni o Kina. ", Ma ka hālāwai kūkā, e pili ana i ka 6000 ~ 8000 poʻe e kūkākūkā i ka API intermediates, alahele inhibitor, a me ka hoʻomaikaʻi a me ka hana hou, a laila i ke kumu o nā lāʻau lapaʻau hou i nā ʻaoʻao āpau e ʻimi i ka ʻenehana, nā kulekele a me nā hoʻonā.

22
23

Ke hoʻololi nei ka mākeke a me ka hoʻokō ʻia ʻana o nā kulekele, hoʻomaikaʻi a hoʻololi ʻia nā hui lāʻau lapaʻau kuʻuna, ulu nā hui Biotech hou, a ke ulu nei nā hui CXO e pili ana i preclinical, clinical a me CMC. Ua komo mālie ʻo Kina i ke kūlana o nā lāʻau lapaʻau a me nā lāʻau hou. , laau kemika a me ka laau olaola.

E kūʻē i kēia ʻano, mākou a me nā haneli o nā ʻoihana lāʻau lapaʻau e paʻa pū ana i ka 3rd China International Biological & Chemical Pharmaceutical Industry Conference (The 3rd CMC-China 2021) ma Suzhou, ke kūlanakauhale nui loa o ka ʻoihana lāʻau.Hoʻonohonoho ʻia nā ʻaha kūkā kumuhana ʻeono ma ka ʻaha kūkā, e uhi ana i ke kahua holoʻokoʻa o nā macro-molecules & small molecules, generic and innovative drugs, upper & down streams chain of active pharmaceutical ingredients (API) a me ka hoʻomākaukau lāʻau.

Ma ka 3rd CMC-China conference, e loaʻa iā ʻoe ka wehewehe ʻana i nā kulekele ʻoihana lāʻau lapaʻau a me ka kaʻana like ʻana i ka ʻenehana, e uhi ana i nā lāʻau antibody, nā lāʻau lapaʻau a me ka ʻenehana mRNA, nā lāʻau hou a me nā lāʻau lapaʻau maʻamau i ʻae ʻia, noiʻi a me ka hoʻomohala ʻana, ke kino a me ka hana ʻana. ʻenehana kaua, etc. Ma ka hālāwai kūkā, hiki iā ʻoe ke loaʻa i nā manawa ʻoihana hou aʻe ma kahi o ka lāʻau lapaʻau ikaika (API), nā intermediates pharmaceutical a me nā excipients pharmaceutical, nā mea hoʻopihapiha, nā mea hana, nā mea hana, nā mea hoʻohana, a me ka lāʻau lapaʻau & clinical CRO, CMO a me nā papahana pili MAH.Ma kaʻaha kūkā, e hālāwaiʻoe me kahi hui o nā hoaalohaʻoihana a me nā hoa!


Ka manawa hoʻouna: Sep-28-2021